Skip to main content

Bone Loss clinical trials at UC Health

1 research study open to eligible people

Showing trials for
  • Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

    open to eligible people ages 25 years and up

    Bariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.

    at UCSF

Last updated: